Lead Product(s) : Bromfenac Sodium
Therapeutic Area : Ophthalmology
Study Phase : Phase IV
Sponsor : Bausch & Lomb Incorporated
Deal Size : Inapplicable
Deal Type : Inapplicable
Post-Intravitreal Injection Pain Comparison Using Eye Treatments
Details : Bromfenac Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Retinal Vein Occlusion.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 29, 2025
Lead Product(s) : Bromfenac Sodium
Therapeutic Area : Ophthalmology
Highest Development Status : Phase IV
Sponsor : Bausch & Lomb Incorporated
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
